Clinical trial
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
NCT07417631
Study timeline
Study start (actual)2026-02-03Date precision: day
Registry last updated2026-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
DulaglutideDRUG · verified · RxNorm: dulaglutide
SitagliptinDRUG · verified · RxNorm: sitagliptin
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07417631 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.